The Drug Access & Affordability Initiative and Institute for Health and Social Policy invites you to the International Conference on Drug Pricing and Affordability. This virtual conference will bring ...

By providing expanded data visibility, Doczy.ai™ paves the way for unprecedented, scalable operational efficiencies for healthcare payers ... contract language into pricing and contract ...

According to InvestingPro analysis, the company maintains strong financial health with impressive ... $70 per share currently factored into Amgen's stock price. Clinical trial setbacks could ...

Some lawmakers in Washington state will just not give up on their quest for a state-run single-payer health care system ... administrative efficiency, bulk pricing, and cost controls ...

The fourth-quarter 2024 earnings cycle is here, with quite a few healthcare companies having reported results. Early reports indicate several key growth drivers at play, including increased ...

Some lawmakers in Washington state will just not give up on their quest for a state-run single-payer health ... primary care, dental, vision, and prescription drug benefits, and achieve cost savings ...

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human ...

Time and again, execs have said they're investing big in AI and advanced analytics to improve team efficiency, payer relations ... at MultiCare Health System, which has 14 acute care hospitals ...

A Minnesota federal judge has given preliminary approval to UnitedHealth's agreement to pay $69 million to settle a class-action lawsuit alleging the company prioritized its business relationship with ...